These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 16000607

  • 1. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE, Rabin MS.
    Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [Abstract] [Full Text] [Related]

  • 2. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist Association.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):695-701. PubMed ID: 18439766
    [Abstract] [Full Text] [Related]

  • 3. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA, Cancer Care Ontario, American Society of Clinical Oncology.
    J Clin Oncol; 2007 Dec 01; 25(34):5506-18. PubMed ID: 17954710
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G, European Organisation for Research and Treatment of Cancer-Lung Cancer Group.
    J Natl Cancer Inst; 2007 Mar 21; 99(6):442-50. PubMed ID: 17374834
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
    Dunant A, Pignon JP, Le Chevalier T.
    Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
    Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH, Eastern Cooperative Oncology Group.
    Lung Cancer; 2005 Jun 01; 48(3):389-97. PubMed ID: 15893008
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED, Herbert SM, Hanna NH.
    Ann Surg Oncol; 2006 Mar 01; 13(3):291-301. PubMed ID: 16450219
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant chemotherapy in non-small cell lung cancer.
    Le Chevalier T.
    Semin Oncol; 1998 Aug 01; 25(4 Suppl 9):62-5. PubMed ID: 9728587
    [Abstract] [Full Text] [Related]

  • 12. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)].
    Nakajima E, Katou H.
    Kyobu Geka; 2008 Jan 01; 61(1):4-8. PubMed ID: 18186265
    [Abstract] [Full Text] [Related]

  • 13. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H.
    Lung Cancer; 2004 Aug 01; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant chemotherapy in completely resected non-small-cell lung cancer.
    Pisters KM, Le Chevalier T.
    J Clin Oncol; 2005 May 10; 23(14):3270-8. PubMed ID: 15886314
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.
    BMJ; 1995 Oct 07; 311(7010):899-909. PubMed ID: 7580546
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?
    Geiger S, Schlemmer M, Heinemann V, Stemmler HJ.
    Anticancer Drugs; 2010 Oct 07; 21(9):799-804. PubMed ID: 20679887
    [Abstract] [Full Text] [Related]

  • 17. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
    Berghmans T, Paesmans M, Meert AP, Mascaux C, Lothaire P, Lafitte JJ, Sculier JP.
    Lung Cancer; 2005 Jul 07; 49(1):13-23. PubMed ID: 15949586
    [Abstract] [Full Text] [Related]

  • 18. Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis.
    Nakamura H, Kawasaki N, Taguchi M, Kabasawa K.
    Lung Cancer; 2006 Dec 07; 54(3):325-9. PubMed ID: 16987564
    [Abstract] [Full Text] [Related]

  • 19. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA.
    Clin Lung Cancer; 2004 Sep 07; 6(2):85-98. PubMed ID: 15476594
    [Abstract] [Full Text] [Related]

  • 20. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
    Bunn PA.
    J Natl Compr Canc Netw; 2004 Sep 07; 2 Suppl 2():S31-40. PubMed ID: 19780244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.